YIN Mingke,LI Liang,LYU Yaozhong,et al.Effect of Alcohol Extract of Oroxylum indicum on Reducing Uric Acid and Protecting Kidney in Hyperuricemia Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(14):57-63.
YIN Mingke,LI Liang,LYU Yaozhong,et al.Effect of Alcohol Extract of Oroxylum indicum on Reducing Uric Acid and Protecting Kidney in Hyperuricemia Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(14):57-63. DOI: 10.13422/j.cnki.syfjx.20230636.
Effect of Alcohol Extract of Oroxylum indicum on Reducing Uric Acid and Protecting Kidney in Hyperuricemia Mice
(MHD-80) on reducing uric acid (UA) and protecting the kidney in the hyperuricemia (HUA) model
in vivo
.
Method
2
Potassium oxazine (350 mg·kg
-1
) and adenine (80 mg·kg
-1
) were used to construct an HUA model of mice
in vivo
to evaluate the mechanism related to UA reduction and the protective effect of renal function of MHD-80. Seventy male ICR mice were randomly divided into seven groups, including the normal group, model group, allopurinol group (5 mg·kg
-1
), febusotan group (5 mg·kg
-1
), and MHD-80 low-, medium-, and high-dose groups (3, 6, 12 mg·kg
-1
), with 10 in each group. Except for the normal group, the other groups were given intragastric administration of potassium oxazine and adenine for 14 consecutive days to establish the HUA model. On the 8
th
to 14
th
day after modeling, each group was given corresponding drugs by intragastric administration, once a day. 1 h after the last administration, blood was collected from the eyeballs, and kidney and liver tissues of mice were collected. Serum levels of UA, urea nitrogen (BUN), and creatinine (Cr) and liver activity of xanthine oxidase (XOD) were determined by enzyme colorimetry. Serum contents of tumor necrosis factor-
α
(TNF-
α
) and interleukin-1
β
(IL-1
β
) were determined by enzyme-linked immunosorbent assay (ELISA). Hematoxilin-eosin (HE) staining was used to observe the pathological changes in kidney tissues. The protein expression levels of ATP-binding box transporter G2 (ABCG2) and glucose-facilitating transporter 9 (GLUT9) in kidney tissues were detected by Western blot.
Result
2
In vivo
experiment shows that compared with the normal group, the serum levels of UA, Cr, BUN, inflammatory factors TNF-
α
, IL-1
β
, and liver XOD activity in the serum of mice in the model group were significantly increased (
P
<
0.05,
P
<
0.01), and the expression of GLUT9 in kidney tissues was significantly up-regulated (
P
<
0.05). ABCG2 protein expression was significantly down-regulated (
P
<
0.05), and renal injury was obvious. Compared with the model group, the levels of UA, BUN, Cr, TNF-
α
, IL-1
β
, and liver XOD activity in the serum of mice in the high-dose group of MHD-80 were decreased to different degrees (
P
<
0.05,
P
<
0.01), GLUT9 protein expression was significantly down-regulated (
P
<
0.01), ABCG2 protein expression was significantly up-regulated (
P
<
0.05) in the high-dose group of MHD-80, and the degree of renal injury was reduced.
Conclusion
2
MHD-80 has certain uric acid reduction, anti-inflammatory, and anti-renal injury effects, which are related to inhibiting XOD activity and regulating the expression of ABCG2 and GLUT9 uric acid transporter.
关键词
木蝴蝶醇提物高尿酸血症黄嘌呤氧化酶肾损伤尿酸转运体
Keywords
alcohol extract of Oroxylum indicumhyperuricemiaxanthine oxidaserenal injuryuric acid transporter
references
LIANG G,NIE Y,CHANG Y,et al.Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice[J].Phytomedicine,2019,59:152772.
LEONCINI G,BARNINI C,MANCO L,et al.Uric acid lowering for slowing CKD progression after the CKD-FIX trial:A solved question or still a dilemma?[J].Clin Kidney J,2022,15(9):1666-1674.
MALLAT S G,AL KATTAR S ,TANIOS B Y,et al.Hyperuricemia, hypertension, and chronic kidney disease:An emerging association[J].Curr Hypertens Rep,2016,18(10):74.
SHARAF EL DIN U,SALEM M M,ABDULAZIM D O.Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review[J].J Adv Res,2017,8(5):537-548.
HUA J,HUANG P,ZHU C M,et al.Anti-hyperuricemic and nephroprotective effects of modified Simiao decoction in hyperuricemic mice[J].J Ethnopharmacol,2012,142(1):248-252.
BENN C L,DUA P,GURRELL R,et al.Physiology of hyperuricemia and urate-lowering treatments[J].Front Med (Lausanne),2018,5:160.
PASCART T,RICHETTE P.Investigational drugs for hyperuricemia, an update on recent developments[J].Expert Opin Investig Drugs,2018,27(5):437-444.
KHANNA D,FITZGERALD J D,KHANNA P P,et al.2012 american college of rheumatology guidelines for management of gout. Part 1:Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J].Arthritis Care Res (Hoboken),2012,64(10):1431-1446.
SCHLESINGER N,PADNICK-SILVER L,LAMOREAUX B.Enhancing the response rate to recombinant uricases in patients with gout[J].Bio Drugs,2022,36(2):95-103.
ZHANG R,ZHAN S,LI S,et al.Anti-hyperuricemic and nephroprotective effects of extracts from Chaenomeles sinensis (Thouin) Koehne in hyperuricemic mice[J].Food Funct,2018,9(11):5778-5790.
CHEN M,YE C,ZHU J,et al.Bergenin as a novel urate-lowering therapeutic strategy for hyperuricemia[J].Front Cell Dev Biol,2020,8:703.
LALRINZUALI K,VABEIRYUREILAI M,JAGETIA G C.Investigation of the anti-inflammatory and analgesic activities of ethanol extract of stem bark of sonapatha oroxylum indicum in vivo[J].Int J Inflam,2016,2016:8247014.
CHEN G,TAN M L,LI K K,et al.Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice[J].J Ethnopharmacol,2015,175:14-20.
国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2020:66.
WANG Z,SONG L,LI X,et al.Lactiplantibacillus pentosus P2020 protects the hyperuricemia and renal inflammation in mice[J].Front Nutr,2023,10:1094483.
HUANG J,MA Z F,ZHANG Y,et al.Geographical distribution of hyperuricemia in mainland China:A comprehensive systematic review and meta-analysis[J].Glob Health Res Policy,2020,5(1):52.
LI D Q,ZHAO J,LI S P.High-performance liquid chromatography coupled with post-column dual-bioactivity assay for simultaneous screening of xanthine oxidase inhibitors and free radical scavengers from complex mixture[J].J Chromatogr A,2014,1345:50-56.
CUI D,LIU S,TANG M,et al.Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption[J].Phytomedicine,2020,66:153111.
CHAU Y T,CHEN H Y,LIN P H,et al.Preventive effects of fucoidan and fucoxanthin on hyperuricemic rats induced by potassium oxonate[J].Mar Drugs,2019,doi:10.3390/md17060343http://dx.doi.org/10.3390/md17060343.
ZHANG Y,JIN L,LIU J,et al.Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia[J].J Ethnopharmacol,2018,214:29-36.
WEN S,WANG D,YU H,et al.The time-feature of uric acid excretion in hyperuricemia mice induced by potassium oxonate and adenine[J].Int J Mol Sci,2020,doi:10.3390/ijms21155178http://dx.doi.org/10.3390/ijms21155178.
CHANG Y H,CHIANG Y F,CHEN H Y,et al.Anti-inflammatory and anti-hyperuricemic effects of chrysin on a high fructose corn syrup-induced hyperuricemia rat model via the amelioration of urate transporters and inhibition of NLRP3 inflammasome signaling pathway[J].Antioxidants (Basel),2021,doi:10.3390/ANTIOX10040564http://dx.doi.org/10.3390/ANTIOX10040564.